Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Stage Small Cell Lung Cancer

Clinical trial NCT06480864 · RECRUITING

Trial details

NCT number: NCT06480864
Sponsor: Yunpeng Liu
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Small Cell Lung Cancer

Start date: 2024-08-09
Primary completion: 2025-08-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.